BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29490748)

  • 21. Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery?
    Harrington K; Alvarez-Vallina L; Crittenden M; Gough M; Chong H; Diaz RM; Vassaux G; Lemoine N; Vile R
    Hum Gene Ther; 2002 Jul; 13(11):1263-80. PubMed ID: 12162810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endocytosis in gene therapy with non-viral vectors.
    Perez Ruiz de Garibay A
    Wien Med Wochenschr; 2016 May; 166(7-8):227-35. PubMed ID: 27141862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status of polymeric gene delivery systems.
    Park TG; Jeong JH; Kim SW
    Adv Drug Deliv Rev; 2006 Jul; 58(4):467-86. PubMed ID: 16781003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanotechnology-enabled gene delivery for cancer and other genetic diseases.
    Jiang T; Gonzalez KM; Cordova LE; Lu J
    Expert Opin Drug Deliv; 2023 Apr; 20(4):523-540. PubMed ID: 37017558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gene therapy: new developments].
    Mohr L; Geissler M
    Praxis (Bern 1994); 2002 Dec; 91(51-52):2227-35. PubMed ID: 12564039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vectors and strategies for nonviral cancer gene therapy.
    Pahle J; Walther W
    Expert Opin Biol Ther; 2016; 16(4):443-61. PubMed ID: 26761200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Graphene materials as 2D non-viral gene transfer vector platforms.
    Vincent M; de Lázaro I; Kostarelos K
    Gene Ther; 2017 Mar; 24(3):123-132. PubMed ID: 27874854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viral and non-viral vectors in gene therapy: technology development and clinical trials.
    Lundstrom K; Boulikas T
    Technol Cancer Res Treat; 2003 Oct; 2(5):471-86. PubMed ID: 14529313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors.
    Wang H; Jiang Y; Peng H; Chen Y; Zhu P; Huang Y
    Adv Drug Deliv Rev; 2015 Jan; 81():142-60. PubMed ID: 25450259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Advances in cationic polymers used as nonviral vectors for gene delivery].
    Ren X; Yang L; Liang X; Liu Z; Deng Y
    Sheng Wu Gong Cheng Xue Bao; 2013 May; 29(5):568-77. PubMed ID: 24010355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PiggyBac as a novel vector in cancer gene therapy: current perspective.
    Mirzaei H; Sahebkar A; Jaafari MR; Hadjati J; Javanmard SH; Mirzaei HR; Salehi R
    Cancer Gene Ther; 2016; 23(2-3):45-7. PubMed ID: 26742580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled release systems for DNA delivery.
    Pannier AK; Shea LD
    Mol Ther; 2004 Jul; 10(1):19-26. PubMed ID: 15233938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-focusing therapeutic gene delivery with intelligent gene vector swarms: intra-swarm signalling through receptor transgene expression in targeted cells.
    Tolmachov OE
    Artif Intell Med; 2015 Jan; 63(1):1-6. PubMed ID: 25547266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection.
    Douglas KL
    Biotechnol Prog; 2008; 24(4):871-83. PubMed ID: 18335953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-viral strategies for ocular gene delivery.
    Oliveira AV; Rosa da Costa AM; Silva GA
    Mater Sci Eng C Mater Biol Appl; 2017 Aug; 77():1275-1289. PubMed ID: 28532005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant polymers for cancer gene therapy: a minireview.
    Haider M; Hatefi A; Ghandehari H
    J Control Release; 2005 Dec; 109(1-3):108-19. PubMed ID: 16263190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Balancing protection and release of DNA: tools to address a bottleneck of non-viral gene delivery.
    Grigsby CL; Leong KW
    J R Soc Interface; 2010 Feb; 7 Suppl 1(Suppl 1):S67-82. PubMed ID: 19734186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies for cancer gene-delivery improvement by non-viral vectors.
    Santana-Armas ML; Tros de Ilarduya C
    Int J Pharm; 2021 Mar; 596():120291. PubMed ID: 33524527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial vectors for imaging and cancer gene therapy: a review.
    Cronin M; Stanton RM; Francis KP; Tangney M
    Cancer Gene Ther; 2012 Nov; 19(11):731-40. PubMed ID: 22996740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy.
    Kasala D; Yoon AR; Hong J; Kim SW; Yun CO
    Nanomedicine (Lond); 2016 Jul; 11(13):1689-713. PubMed ID: 27348247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.